137 related articles for article (PubMed ID: 7464118)
1. Inhibition of androgen aromatization in human breast cancer.
Abul-Hajj YJ
J Steroid Biochem; 1980 Dec; 13(12):1395-400. PubMed ID: 7464118
[No Abstract] [Full Text] [Related]
2. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
Kellis JT; Vickery LE
Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
Santner SJ; Rosen H; Osawa Y; Santen RJ
J Steroid Biochem; 1984 Jun; 20(6A):1239-42. PubMed ID: 6748639
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of estrogen synthesis in human breast tumors by testololactone and bromoandrostenedione.
Budnick RM; Dao TL
Steroids; 1980 May; 35(5):533-41. PubMed ID: 7394858
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
Abul-Hajj YJ
Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
[TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanism of action of the aromatase inhibitor, 4-hydroxyandrostenedione.
Abul-Hajj YJ
Steroids; 1983 Jun; 41(6):783-90. PubMed ID: 6665821
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
Brueggemeier RW; Floyd EE; Counsell RE
J Med Chem; 1978 Oct; 21(10):1007-11. PubMed ID: 722711
[TBL] [Abstract][Full Text] [Related]
8. Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
Dowsett M; Santner SJ; Santen RJ; Jeffcoate SL; Smith IE
Br J Cancer; 1985 Jul; 52(1):31-5. PubMed ID: 4015950
[TBL] [Abstract][Full Text] [Related]
9. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
Dao TL
Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
[TBL] [Abstract][Full Text] [Related]
10. Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
Bellino FL; Gilani SS; Eng SS; Osawa Y; Duax WL
Biochemistry; 1976 Oct; 15(21):4730-6. PubMed ID: 974087
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide.
Graves PE; Salhanick HA
Endocrinology; 1979 Jul; 105(1):52-7. PubMed ID: 446416
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
[TBL] [Abstract][Full Text] [Related]
13. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
Marcotte PA; Robinson CH
Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
[TBL] [Abstract][Full Text] [Related]
14. Evidence of the direct aromatization of testosterone and different aromatization sites for testosterone and androstenedione in human placental microsomes.
Bellino FL; Osawa Y
Biochemistry; 1974 Apr; 13(9):1925-31. PubMed ID: 4152129
[No Abstract] [Full Text] [Related]
15. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
MacIndoe JH; Woods GR; Etre LA; Covey DF
Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
[TBL] [Abstract][Full Text] [Related]
16. Cooperative interaction of reduced pyridine nucleotides with estrogen synthetase of human placental microsomes.
Milewich L; Hendricks TS; Masters BS; Frenkel RA; MacDonald PC
Arch Biochem Biophys; 1981 Oct; 211(2):530-6. PubMed ID: 7305387
[No Abstract] [Full Text] [Related]
17. The flux of intermediates and products in aromatizaton of C19 steroids by human placental microsomes.
Braselton WE; Engel LL; Orr JC
Eur J Biochem; 1974 Oct; 48(1):35-43. PubMed ID: 4155685
[No Abstract] [Full Text] [Related]
18. Overview of recent development of aromatase inhibitors.
Brodie AM
Cancer Res; 1982 Aug; 42(8 Suppl):3312s-3314s. PubMed ID: 7083192
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
